Press Releases
TrialScope Launches New SaaS Clinical Trial Disclosure Management Tool: Core Disclosure
TrialScope, the global leader in clinical trial transparency and compliance solutions announced the launch of its newest solution, Core Disclosure. Promoting a new level...
News
Aridis Is Enrolling Patients in Pivotal Trial of Its Antibiotic-resistant Pneumonia Therapy Aerucin
Aridis Pharmaceuticals, Inc., a biopharmaceutical company applying proprietary technologies to produce novel anti-infectives and immunotherapies for infectious diseases, announced that it is now actively...
Press Releases
Priorclave announce Printer up-grade on lab autoclaves,improving customer experience
Now available on all new laboratory autoclaves and research grade sterilisers leaving the Priorclave production where a printer is required will benefit from inclusion...
Press Releases
RedHill Biopharma Announces Positive and Unanimous DSMB Recommendation for Continuation of Phase III Study with RHB-104 for Crohn’s Disease
RedHill Biopharma Ltd. , a specialty biopharmaceutical company primarily focused on late clinical-stage development and commercialization of proprietary, orally-administered, small molecule drugs for gastrointestinal...
Press Releases
EC Grants Marketing Authorization for Gilead’s Vosevi for the Treatment of All Genotypes of Chronic Hepatitis C
Gilead Sciences, Inc announced that the European Commission has granted marketing authorization for Vosevi® (sofosbuvir 400mg/velpatasvir 100mg/voxilaprevir 100mg), as a once-daily single tablet regimen...
Clinical Trials
Thermo Fisher Scientific Advances Innovation for the Clinic at AACC 2017
Clinical and laboratory personnel with the need to store vaccines, pharmaceuticals and other molecular or biological samples safely can benefit from a new series...
Press Releases
Teva Announces Launch of Generic Epiduo® in the United States
Teva Pharmaceutical Industries Ltd. announced the launch of generic Epiduo®1 (adapalene and benzoyl peroxide) gel, 0.1%/2.5% in the U.S. Adapalene and...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read